Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment
dc.contributor.author | Megías Vericat, J. | |
dc.contributor.author | Montesinos, P. | |
dc.contributor.author | Herrero, M. | |
dc.contributor.author | Moscardó, F. | |
dc.contributor.author | Bosó, V. | |
dc.contributor.author | Martínez Cuadrón, D. | |
dc.contributor.author | Rojas Orellana, Luis | |
dc.contributor.author | Rodríguez Veiga, R. | |
dc.contributor.author | Boluda, B. | |
dc.contributor.author | Sendra, L. | |
dc.contributor.author | Cervera, J. | |
dc.contributor.author | Poveda, J. | |
dc.contributor.author | Sanz, M. | |
dc.contributor.author | Aliño, S. | |
dc.date.accessioned | 2020-07-02T23:19:53Z | |
dc.date.available | 2020-07-02T23:19:53Z | |
dc.date.issued | 2017 | |
dc.fuente.origen | Converis | |
dc.identifier.doi | 10.1080/10428194.2017.1323267 | |
dc.identifier.issn | 1042-8194 | |
dc.identifier.issn | 1029-2403 | |
dc.identifier.uri | https://doi.org/10.1080/10428194.2017.1323267 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/31003 | |
dc.issue.numero | No. 12 | |
dc.language.iso | en | |
dc.nota.acceso | Contenido parcial | |
dc.pagina.final | 2894 | |
dc.pagina.inicio | 2880 | |
dc.revista | Leukemia & Lymphoma | es_ES |
dc.rights | acceso restringido | |
dc.subject.ddc | 610 | |
dc.subject.dewey | Medicina y salud | es_ES |
dc.subject.other | Leucemia mieloide | es_ES |
dc.subject.other | Quimioterapia | es_ES |
dc.subject.other | Citarabina | es_ES |
dc.title | Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment | es_ES |
dc.type | artículo | |
dc.volumen | Vol. 58 | |
sipa.codpersvinculados | 135613 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment.pdf
- Size:
- 2.79 KB
- Format:
- Adobe Portable Document Format
- Description: